Protamine neutralizes CSPG-mediated inhibition of oligodendrocyte differentiation

The research group of researcher Akihiro Fujikawa and Professor Masaharu Noda of the National Institute for Basic Biology developed a screening method to obtain neutralizing agents for canceling the inhibitory effects of CSPGs on oligodendrocyte differentiation. The group found that the inhibitory activity of a representative extracellular matrix CSPG molecule, aggrecan, was neutralized by a polycationic peptide, protamine, that is clinically used to stop the anticoagulant effect of heparin. …read more

Source: EurekAlert

(Visited 18 times, 1 visits today)

Site Footer

Sliding Sidebar